DOI:
10.1055/s-00000034
Klinische Pädiatrie
LinksClose Window
References
Yokota S. et al.
Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial.
Lancet 2008; 371 ((9617)) 998-1006
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.